metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Influence of the degree of anaemia on the prognosis of older adults with heart f...
Journal Information
Vol. 158. Issue 4.
Pages 167-172 (February 2022)
Share
Share
Download PDF
More article options
Visits
4
Vol. 158. Issue 4.
Pages 167-172 (February 2022)
Original article
Influence of the degree of anaemia on the prognosis of older adults with heart failure (SPAN-HF study)
Influencia del grado de anemia en el pronóstico de los pacientes de edad avanzada con insuficiencia cardíaca (Estudio SPAN-HF)
Visits
4
Jordi Grau Amorósa,
Corresponding author
11426jga@comb.cat

Corresponding author.
, José Ángel García Garcíab, José Antonio Mira Escartíb, Anna Serrado Iglesiasa, M. Carmen Moreno Garcíac, Luis Manzanod, M. Angustias Quesada Simóne, Melitón Francisco Dávila Ramosf, Jesús Casado Cerradag, Álvaro González Francoh, Manuel Montero-Pérez-Barqueroi, on behalf of the researchers of the RICA Group
a Hospital Municipal de Badalona, Badalona, Spain
b Hospital Ntra. Sra. de Valme, Sevilla, Spain
c Servicio de Medicina Interna, Hospital de Manises, Manises, Valencia, Spain
d Servicio de Medicina Interna, Hospital Universitario Ramón y Cajal, Universidad de Alcalá (IRYCIS), Madrid, Spain
e Servicio de Medicina Interna, Hospital Universitario La Paz, Madrid, Spain
f Servicio de Medicina Interna, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain
g Servicio de Medicina Interna, Hospital Universitario de Getafe, Madrid, Spain
h Servicio de Medicina Interna, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
i Servicio de Medicina Interna, IMIBIC/Hospital Reina Sofía, Universidad de Córdoba, Córdoba, Spain
Ver más
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (3)
Table 1. Baseline values of the variables included in the study.
Table 2. Cox regression for death or readmission for any cause.
Table 3. Cox regression for death and readmission for heart failure.
Show moreShow less
Additional material (4)
Abstract
Objective

To assess whether a sustained optimal haemoglobin value in the 3 months after admission for heart failure (HF) decompensation reduces morbidity and mortality during the 12 months after admission for acute HF.

Patients and method

Retrospective study of the 1408 patients older than 65 years included in the RICA registry divided into 3 groups: no anaemia (group A), recovered anaemia (group B), and persistent anaemia (group C), according to haemoglobin levels on admission, and 3 months after discharge. Kaplan-Meier curves were constructed, comparing the groups using the log-rank test and a Cox regression model was performed to analyse survival.

Results

578 (41.1%), 299 (21.2%) and 531 (37.7%) were included in groups A, B and C, respectively. We recorded a total of 768 deaths and readmissions. There were 23 (4%), 12 (4%) and 49 (9.2%), (p = 0.001) individuals who died due to HF and 154 (27%), 73 (24%) and 193 (36%) (P < 0.001) admissions for this pathology, respectively. Patients with persistent anaemia had a higher risk of death (RR 1.29, 95% CI 1.04−1.61, P = 0.024) or readmission (1.92, 95% CI 1.16–3, 19; P = 0.012) due to HF.

Conclusions

Persistent anaemia in the months after admission for HF increases morbidity and mortality in the subsequent year.

Keywords:
Heart failure
Anaemia
Prognosis
Morbidity
Mortality
Resumen
Objetivo

Evaluar si un valor óptimo de hemoglobina sostenido en los 3 meses posteriores al ingreso por descompensación de insuficiencia cardíaca (IC) reduce la morbimortalidad durante los 12 meses posteriores a un ingreso por IC aguda.

Pacientes y método

Estudio retrospectivo de los 1408 pacientes mayores de 65 años incluidos en el registro RICA divididos en 3 grupos: sin anemia (grupo A), anemia recuperada (grupo B) y anemia persistente (grupo C), según los niveles de hemoglobina en el ingreso y a los 3 meses tras el alta. Se construyeron curvas de Kaplan-Meier, comparando los grupos mediante la prueba de log-rank y se realizó un modelo de regresión de Cox para analizar la supervivencia.

Resultados

Se incluyeron 578 (41,1%), 299 (21,2%) y 531 (37,7%) en los grupos A, B y C, respectivamente. Registramos un total de 768 muertes y reingresos. Hubo 23 (4%), 12 (4%) y 49 (9,2%) (p = 0,001) individuos que fallecieron debido a la IC, y 154 (27%), 73 (24%) y 193 (36%) (p < 0,001) reingresaron por esta patología, respectivamente. Los pacientes con anemia persistente tuvieron un riesgo superior de fallecimiento (RR: 1,29; IC95% de 1,04–1,61; p = 0,024) o reingreso (1,92; IC95% de 1,16–3,19; p = 0,012) por IC.

Conclusiones

La anemia persistente en los meses posteriores a un ingreso por IC aumenta la morbimortalidad en el año posterior.

Palabras clave:
Insuficiencia cardiaca
Anemia
Pronóstico
Morbilidad
Mortalidad

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos